Cardiac mesh morphing method for finite element modeling of heart failure with preserved ejection fraction

2021 ◽  
pp. 104937
Author(s):  
Jonathan Weissmann ◽  
Christopher J. Charles ◽  
A. Mark Richards ◽  
Choon Hwai Yap ◽  
Gil Marom
Keyword(s):  
Heart Failure ◽  
Finite Element ◽  
Ejection Fraction ◽  
Finite Element Modeling ◽  
Preserved Ejection Fraction ◽  
Mesh Morphing ◽  
Element Modeling

scholarly journals Mesh-morphing algorithms for specimen-specific finite element modeling

2008 ◽  
Vol 41 (7) ◽  
pp. 1381-1389 ◽  
Author(s):  
Ian A. Sigal ◽  
Michael R. Hardisty ◽  
Cari M. Whyne
Keyword(s):  
Finite Element ◽  
Finite Element Modeling ◽  
Mesh Morphing ◽  
Element Modeling

Acute heart failure with preserved ejection fraction and long-term Readmisions

2008 ◽  
Vol 7 ◽  
pp. 62-63
Author(s):  
J NUNEZ ◽  
L MAINAR ◽  
G MINANA ◽  
R ROBLES ◽  
J SANCHIS ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Acute Heart Failure ◽  
Preserved Ejection Fraction

Exact First Order Finite Element Modeling for Eddy Current NDE

1991 ◽  
Vol 3 (1) ◽  
pp. 235-253 ◽  
Author(s):  
L. D. Philipp ◽  
Q. H. Nguyen ◽  
D. D. Derkacht ◽  
D. J. Lynch ◽  
A. Mahmood
Keyword(s):  
Finite Element ◽  
Finite Element Modeling ◽  
Eddy Current ◽  
Element Modeling ◽  
First Order ◽  
Eddy Current Nde

Galectin-3 in Heart Failure – Linking Fibrosis, Remodelling and Progression

2010 ◽  
Vol 6 (2) ◽  
pp. 33 ◽  
Author(s):  
Christopher R deFilippi ◽  
G Michael Felker ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Risk Stratification ◽  
Cardiac Fibrosis ◽  
The Elderly ◽  
Preserved Ejection Fraction ◽  
Heart Failure Patients ◽  
Large Populations ◽  
Galectin 3

For many with heart failure, including the elderly and those with a preserved ejection fraction, both risk stratification and treatment are challenging. For these large populations and others there is increasing recognition of the role of cardiac fibrosis in the pathophysiology of heart failure. Galectin-3 is a novel biomarker of fibrosis and cardiac remodelling that represents an intriguing link between inflammation and fibrosis. In this article we review the biology of galectin-3, recent clinical research and its application in the management of heart failure patients.

Sign in / Sign up

Export Citation Format

Share Document